Term Name: tesevatinib
Synonyms: 7-{[(3aR,5R,6aS)-2-methyl-octahydrocyclopenta[c]pyrrol-5-yl]methoxy}-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine, EXEL 7647, EXEL-7647, EXEL7647, KD 019, KD-019, KD019, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-{[(3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl]methoxy}quinazolin-4-amine, tesevatinib, tesevatinibum, XL 647, XL-647, XL647
Definition: A member of the class of quinazolines that is quinazoline substituted by (3,4-dichloro-2-fluorophenyl)amino, methoxy, and [(3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl]methoxy groups at positions 4, 6 and 7, respectively. It is a multi-target tyrosine kinase inhibitor of EGFR, ErbB2, KDR, Flt4 and EphB4 and exhibits anti-cancer properties.
Ontology: ChEBI [CHEBI:167674]  ( EBI )

Relationships
is a type of: aromatic ether dichlorobenzene diether monofluorobenzenes quinazolines secondary amino compound tertiary amino compound
has_role: antineoplastic agent EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor epidermal growth factor receptor antagonist